Profile data is unavailable for this security.
About the company
Biostax Corp. is a developer and marketer of pharmaceutical, biotechnology, and MedTech products. The Company has partnerships in the fields of autoimmunity and immune restoration and are able to deliver solutions today for people that are living with autoimmunity, chronic inflammation, infection, and cancer. Its internal and partner programs comprised of JKB-122, an investigational small molecule, long-acting toll-like receptor 4 (TLR4) antagonist developed for autoimmune hepatitis, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) that has demonstrated anti-fibrotic, immuno-modulating, and anti-inflammatory activities in preclinical models; Lodonal, is a once-a-day immune system regulator for the management of human immunodeficiency virus and acquired immune deficiency syndrome (HIV/AIDS), and LDN, which is a compound formula that is purported to provide immune-modulating benefits that include cancer, pain, autoimmune, and anti-aging.
- Revenue in USD (TTM)0.00
- Net income in USD-1.57m
- Incorporated1993
- Employees--
- LocationBiostax Corp2431 Aloma Ave #124WINTER PARK 32792United StatesUSA
- Phone+1 (407) 680-3097
- Fax+1 (407) 641-8668
- Websitehttps://www.biostaxcorp.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eloxx Pharmaceuticals Inc | 0.00 | -20.48m | 2.67m | 18.00 | -- | -- | -- | -- | -9.06 | -9.06 | 0.00 | -6.53 | 0.00 | -- | -- | 0.00 | -124.43 | -115.27 | -- | -155.33 | -- | -- | -- | -- | -- | -16.69 | -- | -- | -- | -- | 45.95 | -- | -22.56 | -- |
| Aridis Pharmaceuticals Inc | 22.36m | -1.14m | 2.79m | 37.00 | -- | -- | -- | 0.1246 | -0.1845 | -0.1845 | 0.7074 | -0.2648 | 2.40 | -- | 58.45 | 604,297.30 | -12.24 | -120.16 | -- | -678.29 | -- | -- | -5.11 | -1,559.63 | -- | -- | -- | -- | 101.37 | 29.16 | 34.43 | -- | -34.84 | -- |
| Virax Biolabs Group Ltd | 0.00 | -1.71m | 2.79m | 5.00 | -- | -- | -- | -- | -1.50 | -1.50 | 0.00 | -0.8568 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 0.0223 | -112.29 | -- | -- | -100.00 | -- | -162.50 | -- | -- | -- |
| Novelstem International Corp | 15.00k | -4.22m | 2.82m | 15.00 | -- | -- | -- | 187.84 | -0.09 | -0.09 | 0.0003 | -0.0478 | 0.0065 | -- | 10.00 | -- | -172.16 | -- | -1,011.77 | -- | -- | -- | -26,418.53 | -- | -- | -8.40 | 2.34 | -- | 0.00 | -- | -446.84 | -- | -- | -- |
| Aptevo Therapeutics Inc | 0.00 | -27.31m | 2.91m | 40.00 | -- | 0.0786 | -- | -- | -98.49 | -97.90 | 0.00 | 9.06 | 0.00 | -- | -- | 0.00 | -103.85 | -47.16 | -134.86 | -85.03 | -- | -- | -- | -583.47 | -- | -- | 0.00 | -- | -100.00 | -- | -365.90 | -- | -- | -- |
| AgriFORCE Growing Systems Ltd | 16.28k | -13.34m | 2.93m | 7.00 | -- | 0.2838 | -- | 179.76 | -10.78 | -10.78 | 0.0039 | 0.396 | 0.0009 | -- | 0.443 | 2,325.71 | -74.39 | -78.95 | -100.77 | -109.86 | 16.58 | -- | -81,946.25 | -243,182.50 | 0.8186 | -1.30 | 0.1913 | -- | -- | -- | 8.85 | -- | 48.61 | -- |
| Biostax Corp | 0.00 | -1.57m | 2.93m | -- | -- | -- | -- | -- | -0.0188 | -0.0188 | 0.00 | -0.058 | 0.00 | -- | -- | -- | -390.77 | -81.51 | -- | -- | -- | -- | -- | -- | -- | -6.05 | -- | -- | -- | -- | 53.32 | -- | -- | -- |
| Veritas Farms Inc | 730.65k | -6.15m | 2.93m | 17.00 | -- | 14.49 | -- | 4.01 | -0.1319 | -0.1319 | 0.0136 | 0.0013 | 0.0877 | 0.8064 | 7.80 | 42,979.41 | -69.02 | -72.11 | -123.21 | -93.59 | -220.09 | 24.07 | -787.27 | -177.79 | 0.1392 | -5.56 | 0.95 | -- | -63.42 | -0.9427 | 23.68 | -- | -52.93 | -- |
| ENDRA Life Sciences Inc | 0.00 | -9.89m | 2.97m | 21.00 | -- | 0.7939 | -- | -- | -1.26 | -1.26 | 0.00 | 0.3388 | 0.00 | -- | -- | 0.00 | -168.89 | -132.00 | -228.29 | -157.28 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 23.67 | -- | -19.46 | -- |
| Mosaic Immunoengineering Inc | 0.00 | -897.69k | 3.04m | 3.00 | -- | -- | -- | -- | -0.1245 | -0.1245 | 0.00 | -0.8498 | 0.00 | -- | -- | 0.00 | -789.46 | -- | -- | -- | -- | -- | -- | -- | -- | -26.91 | -- | -- | -- | -- | 57.65 | -- | -- | -- |
| Resonate Blends Inc | 101.41k | -4.72m | 3.13m | 6.00 | -- | -- | -- | 30.82 | -0.0537 | -0.0537 | 0.0012 | -0.0007 | 0.0328 | -- | -- | -- | -152.56 | -680.29 | -- | -- | -34.87 | -78.88 | -4,657.83 | -12,895.26 | -- | -0.7413 | 1.02 | -- | -66.73 | -56.57 | -316.63 | -- | -- | -- |
| Seelos Therapeutics Inc | 1.97m | -27.12m | 3.13m | 10.00 | -- | -- | -- | 1.59 | -44.59 | -44.59 | 2.16 | -17.36 | 0.1449 | -- | 2.24 | 131,600.00 | -198.99 | -180.05 | -- | -386.76 | -- | -- | -1,373.61 | -9,612.88 | -- | -- | -- | -- | -- | -- | 48.48 | -- | -- | -- |
| Revelation Biosciences Inc | 0.00 | -8.96m | 3.15m | 9.00 | -- | 0.3327 | -- | -- | -32.09 | -32.09 | 0.00 | 5.80 | 0.00 | -- | -- | 0.00 | -54.61 | -- | -91.95 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 98.89 | -- | -- | -- |
